A detailed history of Nuveen Asset Management, LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 255,642 shares of RXST stock, worth $11.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
255,642
Previous 559,113 54.28%
Holding current value
$11.5 Million
Previous $33.6 Million 62.44%
% of portfolio
0.0%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.78 - $57.04 $12.4 Million - $17.3 Million
-303,471 Reduced 54.28%
255,642 $12.6 Million
Q2 2024

Aug 09, 2024

SELL
$50.42 - $64.29 $9.39 Million - $12 Million
-186,280 Reduced 24.99%
559,113 $33.6 Million
Q1 2024

May 13, 2024

BUY
$35.51 - $57.92 $1.76 Million - $2.88 Million
49,688 Added 7.14%
745,393 $38.4 Million
Q4 2023

Feb 14, 2024

BUY
$20.91 - $40.9 $5.53 Million - $10.8 Million
264,228 Added 61.24%
695,705 $28.1 Million
Q3 2023

Nov 14, 2023

BUY
$27.05 - $33.37 $8.41 Million - $10.4 Million
310,992 Added 258.12%
431,477 $12 Million
Q2 2023

Aug 14, 2023

BUY
$16.37 - $28.9 $869,787 - $1.54 Million
53,133 Added 78.89%
120,485 $3.47 Million
Q1 2023

May 15, 2023

BUY
$12.58 - $16.68 $43,702 - $57,946
3,474 Added 5.44%
67,352 $1.12 Million
Q4 2022

Feb 14, 2023

SELL
$9.93 - $14.2 $35,618 - $50,935
-3,587 Reduced 5.32%
63,878 $810,000
Q3 2022

Nov 14, 2022

BUY
$11.19 - $15.85 $25,222 - $35,725
2,254 Added 3.46%
67,465 $810,000
Q2 2022

Aug 15, 2022

BUY
$10.61 - $16.66 $427,593 - $671,414
40,301 Added 161.79%
65,211 $918,000
Q1 2022

May 16, 2022

BUY
$8.97 - $14.03 $223,442 - $349,487
24,910 New
24,910 $290,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.